These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28903377)

  • 41. MET Receptor Tyrosine Kinase Inhibition Reduces Interferon-Gamma (IFN-γ)-Stimulated PD-L1 Expression through the STAT3 Pathway in Melanoma Cells.
    Song KY; Han YH; Roehrich H; Brown ME; Torres-Cabala C; Giubellino A
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcriptional Reprogramming and Constitutive PD-L1 Expression in Melanoma Are Associated with Dedifferentiation and Activation of Interferon and Tumour Necrosis Factor Signalling Pathways.
    Ahn A; Rodger EJ; Motwani J; Gimenez G; Stockwell PA; Parry M; Hersey P; Chatterjee A; Eccles MR
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation Between Tumor-Associated Macrophage and Immune Checkpoint Molecule Expression and Its Prognostic Significance in Cutaneous Melanoma.
    Kim YJ; Won CH; Lee MW; Choi JH; Chang SE; Lee WJ
    J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32756500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases.
    In GK; Poorman K; Saul M; O'Day S; Farma JM; Olszanski AJ; Gordon MS; Thomas JS; Eisenberg B; Flaherty L; Weise A; Daveluy S; Gibney G; Atkins MB; Vanderwalde A
    Oncotarget; 2020 Aug; 11(33):3118-3128. PubMed ID: 32913556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pigmented Epithelioid Melanocytoma (Animal Types of Melanoma) on the Nose.
    Ohuchi K; Fujimura T; Kambayashi Y; Tono H; Ohtake E; Hashimoto A; Aiba S
    Case Rep Oncol; 2018; 11(2):378-382. PubMed ID: 30022939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intertumoral Genetic Heterogeneity Generates Distinct Tumor Microenvironments in a Novel Murine Synchronous Melanoma Model.
    Qin SS; Han BJ; Williams A; Jackson KM; Jewell R; Chacon AC; Lord EM; Linehan DC; Kim M; Reuben A; Gerber SA; Prieto PA
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34064795
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    Blevins DJ; Hanley R; Bolduc T; Powell DA; Gignac M; Walker K; Carr MD; Hof F; Wulff JE
    ACS Med Chem Lett; 2019 Aug; 10(8):1187-1192. PubMed ID: 31413804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Erratum: SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression.
    Berzaghi R; Maia VS; Pereira FV; Melo FM; Guedes MS; Origassa CS; Scutti JB; Matsuo AL; Câmara NO; Rodrigues EG; Travassos LR
    Sci Rep; 2017 Feb; 7():42827. PubMed ID: 28220798
    [No Abstract]   [Full Text] [Related]  

  • 49. Correction: Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma.
    Cancer Res; 2017 May; 77(10):2770. PubMed ID: 28507051
    [No Abstract]   [Full Text] [Related]  

  • 50. [Research progress on anti-PD-L1 antibody in treatment of malignant melanoma].
    Zhonghua Bing Li Xue Za Zhi; 2017 Jul; 46(7):515-518. PubMed ID: 28728233
    [No Abstract]   [Full Text] [Related]  

  • 51. Conjunctival stromal tumor.
    Lagvankar M; Alam MS
    Oman J Ophthalmol; 2023; 16(2):388-389. PubMed ID: 37602162
    [No Abstract]   [Full Text] [Related]  

  • 52. Predictors of responses to immune checkpoint blockade in advanced melanoma.
    Jacquelot N; Roberti MP; Enot DP; Rusakiewicz S; Ternès N; Jegou S; Woods DM; Sodré AL; Hansen M; Meirow Y; Sade-Feldman M; Burra A; Kwek SS; Flament C; Messaoudene M; Duong CPM; Chen L; Kwon BS; Anderson AC; Kuchroo VK; Weide B; Aubin F; Borg C; Dalle S; Beatrix O; Ayyoub M; Balme B; Tomasic G; Di Giacomo AM; Maio M; Schadendorf D; Melero I; Dréno B; Khammari A; Dummer R; Levesque M; Koguchi Y; Fong L; Lotem M; Baniyash M; Schmidt H; Svane IM; Kroemer G; Marabelle A; Michiels S; Cavalcanti A; Smyth MJ; Weber JS; Eggermont AM; Zitvogel L
    Nat Commun; 2017 Sep; 8(1):592. PubMed ID: 28928380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV/p16 in head and neck cancer treated with bio- or chemo-radiotherapy.
    Ou D; Adam J; Garberis I; Blanchard P; Nguyen F; Levy A; Casiraghi O; Gorphe P; Breuskin I; Janot F; Temam S; Scoazec JY; Deutsch E; Tao Y
    Oncoimmunology; 2017; 6(9):e1341030. PubMed ID: 28932643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Frequent PD-L1 Expression in Malignant Melanomas of the Vulva.
    Saleh B; Kriegsmann J; Falk S; Aulmann S
    Int J Gynecol Pathol; 2018 Sep; 37(5):477-481. PubMed ID: 28914674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protein Expression of Programmed Death 1 Ligand 1 and HER2 in Gastric Carcinoma.
    Oki E; Okano S; Saeki H; Umemoto Y; Teraishi K; Nakaji Y; Ando K; Zaitsu Y; Yamashita N; Sugiyama M; Nakashima Y; Ohgaki K; Oda Y; Maehara Y
    Oncology; 2017; 93(6):387-394. PubMed ID: 28910818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HLA Class I Antigen Expression in Conjunctival Melanoma Is Not Associated With PD-L1/PD-1 Status.
    Cao J; Brouwer NJ; Jordanova ES; Marinkovic M; van Duinen SG; de Waard NE; Ksander BR; Mulder A; Claas FHJ; Heemskerk MHM; Jager MJ
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1005-1015. PubMed ID: 29450544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lactate secreted by glycolytic conjunctival melanoma cells attracts and polarizes macrophages to drive angiogenesis in zebrafish xenografts.
    Yin J; Forn-Cuní G; Surendran AM; Lopes-Bastos B; Pouliopoulou N; Jager MJ; Le Dévédec SE; Chen Q; Snaar-Jagalska BE
    Angiogenesis; 2024 Jun; ():. PubMed ID: 38842752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer.
    Aghbash PS; Hemmat N; Baradaran B; Mokhtarzadeh A; Poortahmasebi V; Oskuee MA; Baghi HB
    Oncol Res; 2022; 30(3):99-116. PubMed ID: 37305016
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Update on Immune Checkpoint Inhibitors for Conjunctival Melanoma.
    Sa HS; Daniel C; Esmaeli B
    J Ophthalmic Vis Res; 2022; 17(3):405-412. PubMed ID: 36160103
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathologic features and survival outcomes of ocular melanoma: a series of 31 cases from a tertiary university hospital.
    Kestel S; Göçün FPU; Öğüt B; Erdem Ö
    J Pathol Transl Med; 2022 Jul; 56(4):187-198. PubMed ID: 35501671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.